We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.05%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
+$134M
(+15%)
Cap. Flow
+$101M
Cap. Flow
% of AUM
9.82%
Top 10 Holdings %
Top 10 Hldgs %
32.7%
Holding
2,551
New
200
Increased
686
Reduced
655
Closed
183
Avg Time Held Equity + Options
1.8
years
Top 10 Avg Time Held Equity + Options
1.4
years
Top 20 Avg Time Held Equity + Options
1.4
years
Avg Time Held Equity only
1.8
years
Top 10 Avg Time Held Equity only
1.4
years
Top 20 Avg Time Held Equity only
1.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$59.5M |
| 2 |
Microsoft
MSFT
|
+$35.4M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$14.4M |
| 4 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$11M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$9.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$34.9M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$14.6M |
| 3 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$6.59M |
| 4 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$3.46M |
| 5 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
+$2.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.06% |
| 2 | Technology | 12.78% |
| 3 | Financials | 6.64% |
| 4 | Communication Services | 4.79% |
| 5 | Healthcare | 4.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
iShares MSCI ACWI ETF
ACWI
$32.8B
| $362K | 0.04% |
4,915
-2,977
| -38% | -$217K |
2016 Q4
10 quarters
|
|
302
Veeva Systems
VEEV
$50.7B
| $361K | 0.04% |
2,227
+281
| +14% | +$40.9K |
2018 Q3
3 quarters
|
|
303
State Street Technology Select Sector SPDR ETF
XLK
$124B
| $360K | 0.04% |
9,228
+960
| +12% | +$36.6K |
2016 Q4
10 quarters
|
|
304
Becton Dickinson
BDX
$52.5B
| $356K | 0.03% |
1,446
+67
| +5% | +$15.6K |
2016 Q4
10 quarters
|
|
305
JPMorgan Ultra-Short Income ETF
JPST
$42.4B
| $354K | 0.03% |
7,021
-11,569
| -62% | -$583K |
2018 Q2
4 quarters
|
|
306
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$937M
| $354K | 0.03% |
17,490
+17,000
| +3,469% | +$331K |
2017 Q1
9 quarters
|
|
307
Cintas
CTAS
$84.2B
| $353K | 0.03% |
5,956
+680
| +13% | +$37.6K |
2016 Q4
10 quarters
|
|
308
Tesla
TSLA
$1.43T
| $353K | 0.03% |
23,715
-2,415
| -9% | -$37.6K |
2016 Q4
10 quarters
|
|
309
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.4B
| $352K | 0.03% |
6,216
+4
| +0.1% | +$222 |
2016 Q4
10 quarters
|
|
310
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.51B
| $351K | 0.03% |
4,398
| – | – |
2018 Q3
3 quarters
|
|
311
Synopsys
SNPS
$88.8B
| $351K | 0.03% |
2,726
+225
| +9% | +$27.1K |
2016 Q4
10 quarters
|
|
|
ALXN
312
DELISTED
Alexion Pharmaceuticals
ALXN
| $347K | 0.03% |
2,646
-229
| -8% | -$29.5K |
2016 Q4
10 quarters
|
|
313
iShares Biotechnology ETF
IBB
$10.7B
| $346K | 0.03% |
3,172
-383
| -11% | -$40.7K |
2016 Q4
10 quarters
|
|
314
S&P Global
SPGI
$124B
| $346K | 0.03% |
1,519
+13
| +0.9% | +$2.84K |
2016 Q4
10 quarters
|
|
315
iShares US Healthcare Providers ETF
IHF
$1.44B
| $343K | 0.03% |
10,015
-5,610
| -36% | -$187K |
2016 Q4
10 quarters
|
|
316
Estee Lauder
EL
$38.5B
| $342K | 0.03% |
1,867
+19
| +1% | +$3.25K |
2016 Q4
10 quarters
|
|
317
ASML
ASML
$632B
| $341K | 0.03% |
1,639
+104
| +7% | +$20.7K |
2016 Q4
10 quarters
|
|
|
AABA
318
DELISTED
Altaba Inc
AABA
| $340K | 0.03% |
4,908
+367
| +8% | +$25.7K |
2017 Q2
8 quarters
|
|
319
Tootsie Roll Industries
TR
$2.95B
| $332K | 0.03% |
11,041
-88
| -0.8% | -$2.76K |
2016 Q4
10 quarters
|
|
320
Chunghwa Telecom
CHT
$36.9B
| $331K | 0.03% |
9,056
-2,981
| -25% | -$107K |
2016 Q4
10 quarters
|
|
321
Intuitive Surgical
ISRG
$150B
| $330K | 0.03% |
1,890
+27
| +1% | +$4.63K |
2016 Q4
10 quarters
|
|
322
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.7B
| $329K | 0.03% |
6,221
+5,006
| +412% | +$262K |
2017 Q2
8 quarters
|
|
323
Novo Nordisk
NVO
$174B
| $323K | 0.03% |
12,644
-146
| -1% | -$3.61K |
2016 Q4
10 quarters
|
|
324
American Water Works
AWK
$26.7B
| $320K | 0.03% |
2,762
+500
| +22% | +$55.2K |
2016 Q4
10 quarters
|
|
325
Zoetis
ZTS
$32.5B
| $320K | 0.03% |
2,819
+46
| +2% | +$4.82K |
2016 Q4
10 quarters
|
|
Similar funds
Parallel Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Parallel Advisors held 2,551 positions worth $1.03B, up 15% from $891M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Parallel Advisors deployed $101M of net new capital in Q2 2019, opening 200 new positions and adding to 686 existing holdings. Its largest new stake was Onto Innovation: 157,557 shares worth $5.47M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 56% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $34.9M trimmed.
- Parallel Advisors's largest Q2 2019 buy was Onto Innovation: 157,557 shares worth $5.47M.
- Parallel Advisors added most to iShares Core S&P Total US Stock Market ETF in Q2 2019, an estimated $59.5M increase.
- Parallel Advisors's biggest Q2 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $34.9M.
- Parallel Advisors fully exited Vanguard Short-Term Treasury ETF in Q2 2019, selling an estimated $553K.
- Parallel Advisors's ten largest holdings make up 33% of its $1.03B portfolio in Q2 2019.
- Parallel Advisors opened 200 new positions and closed 183 in Q2 2019.
- Parallel Advisors's portfolio value rose 15% quarter-over-quarter to $1.03B.
Based on Parallel Advisors's 13F filing for Q2 2019, filed 5 Aug 2019.